PIER Trial: Neoadjuvant Therapy with Panitumumab (P) and Mfolfox-6 in an Enriched Population of Patients with T3 Rectal Adenocarcinoma of the Middle Third with Clear Mesorectal Fascia.
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要